rs116114803

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001009944.3(PKD1):​c.10768C>T​(p.Leu3590Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0315 in 1,569,998 control chromosomes in the GnomAD database, including 941 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 63 hom., cov: 33)
Exomes 𝑓: 0.032 ( 878 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.335

Publications

11 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1-AS1 (HGNC:56035): (PKD1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 16-2093864-G-A is Benign according to our data. Variant chr16-2093864-G-A is described in ClinVar as Benign. ClinVar VariationId is 256894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.335 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0231 (3514/152294) while in subpopulation NFE AF = 0.0379 (2577/68000). AF 95% confidence interval is 0.0367. There are 63 homozygotes in GnomAd4. There are 1656 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.10768C>T p.Leu3590Leu synonymous_variant Exon 36 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.10768C>T p.Leu3590Leu synonymous_variant Exon 36 of 46 1 NM_001009944.3 ENSP00000262304.4

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3512
AN:
152176
Hom.:
63
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00632
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.0114
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.0296
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0379
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0220
AC:
4115
AN:
187406
AF XY:
0.0223
show subpopulations
Gnomad AFR exome
AF:
0.00659
Gnomad AMR exome
AF:
0.00782
Gnomad ASJ exome
AF:
0.0173
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0371
Gnomad NFE exome
AF:
0.0350
Gnomad OTH exome
AF:
0.0233
GnomAD4 exome
AF:
0.0324
AC:
45921
AN:
1417704
Hom.:
878
Cov.:
33
AF XY:
0.0319
AC XY:
22428
AN XY:
703030
show subpopulations
African (AFR)
AF:
0.00498
AC:
162
AN:
32534
American (AMR)
AF:
0.00834
AC:
338
AN:
40534
Ashkenazi Jewish (ASJ)
AF:
0.0166
AC:
424
AN:
25558
East Asian (EAS)
AF:
0.0000532
AC:
2
AN:
37580
South Asian (SAS)
AF:
0.0114
AC:
937
AN:
82214
European-Finnish (FIN)
AF:
0.0348
AC:
1355
AN:
38882
Middle Eastern (MID)
AF:
0.00332
AC:
19
AN:
5726
European-Non Finnish (NFE)
AF:
0.0376
AC:
41165
AN:
1095710
Other (OTH)
AF:
0.0258
AC:
1519
AN:
58966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2857
5714
8571
11428
14285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1546
3092
4638
6184
7730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3514
AN:
152294
Hom.:
63
Cov.:
33
AF XY:
0.0222
AC XY:
1656
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00630
AC:
262
AN:
41570
American (AMR)
AF:
0.0114
AC:
175
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3468
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.00849
AC:
41
AN:
4830
European-Finnish (FIN)
AF:
0.0296
AC:
314
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0379
AC:
2577
AN:
68000
Other (OTH)
AF:
0.0194
AC:
41
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
174
347
521
694
868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0241
Hom.:
24
Bravo
AF:
0.0210

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:2
May 15, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 08, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 27, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19686598, 11058904, 15772804) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal dominant polycystic kidney disease Benign:1
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
6.8
DANN
Benign
0.72
PhyloP100
0.34
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116114803; hg19: chr16-2143865; API